Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 04-Jan-23 8:30 AM View:  | Coya Therapeutics, Inc. (COYA) | 03-Jan-23 | Purchase | 10,000 | -- | -- | 100% 0 to 10.0K | |
| 21-Jun-21 11:03 AM View: | Ohr Pharmaceutical, Inc. (NBSE) | 18-Jun-21 | Market Purchase | 8,000 | $4.75 | $38,000.00 | 36% 22.0K to 30.0K | (3%) |
| 27-Apr-21 4:02 PM View: | Ohr Pharmaceutical, Inc. (NBSE) | 26-Apr-21 | Private Purchase | 12,000 | $5.00 | $60,000.00 | 120% 10.0K to 22.0K | |
| 04-May-20 2:18 PM View: | Ohr Pharmaceutical, Inc. (NBSE) | 30-Apr-20 | Private Purchase | 10,000 | $6.00 | $60,000.00 | 100% 0 to 10.0K | |
| 03-Mar-20 7:11 PM View: | Adma Biologics, Inc. (ADMA) | 28-Feb-20 | Grant | 7,500 | -- | -- | 100% 0 to 7.5K | |
| 08-Jun-18 5:08 PM View: | Esperion Therapeutics, Inc. (ESPR) | 06-Jun-18 | Disposition (other) | 13,000 | -- | -- | (100%) 13.05K to 47 | |
| 08-Jun-18 5:08 PM View: | Esperion Therapeutics, Inc. (ESPR) | 06-Jun-18 | Option Exercise | 13,000 | $16.47 | $214,100.00 | 27660% 47 to 13.05K | |
| 20-Dec-17 5:53 PM View: | Esperion Therapeutics, Inc. (ESPR) | 18-Dec-17 | Disposition (other) | 21,471 | -- | -- | (100%) 21.52K to 47 | |
| 20-Dec-17 5:53 PM View: | Esperion Therapeutics, Inc. (ESPR) | 18-Dec-17 | Option Exercise | 21,471 | $3.70 | $79,442.70 | 45683% 47 to 21.52K | |
| 08-Dec-17 4:42 PM View: | Esperion Therapeutics, Inc. (ESPR) | 05-Dec-17 | Acquisition (other) | 38 | -- | -- | 422% 9 to 47 | |
| 23-Mar-17 4:37 PM View: | Esperion Therapeutics, Inc. (ESPR) | 22-Mar-17 | Market Sale | 312,642 | $38.82 | $12,136,800.00 | (27%) 1.15M to 837.13K | 27% |
| 23-Mar-17 4:37 PM View: | Esperion Therapeutics, Inc. (ESPR) | 21-Mar-17 | Market Sale | 487,358 | $43.48 | $21,190,300.00 | (30%) 1.64M to 1.15M | 35% |
| 09-Mar-17 1:21 PM View: | Cempra, Inc. (MLNT) | 08-Mar-17 | Market Sale | 99,900 | $3.57 | $356,443.00 | (100%) 100.0K to 95 | 92% |
| 09-Mar-17 1:21 PM View: | Cempra, Inc. (MLNT) | 07-Mar-17 | Market Sale | 50,100 | $3.53 | $176,673.00 | (33%) 150.09K to 100.0K | 92% |
| 18-Jan-17 4:17 PM View: | Cempra, Inc. (MLNT) | 13-Jan-17 | Market Sale | 105,460 | $3.40 | $358,564.00 | (41%) 255.56K to 150.09K | 92% |
| 06-Jan-17 5:24 PM View: | Cempra, Inc. (MLNT) | 06-Jan-17 | Market Sale | 437,600 | $3.64 | $1,592,860.00 | (63%) 693.15K to 255.56K | 93% |
| 06-Jan-17 5:24 PM View: | Cempra, Inc. (MLNT) | 05-Jan-17 | Market Sale | 500,000 | $3.20 | $1,600,000.00 | (42%) 1.19M to 693.15K | 92% |
| 09-Mar-16 5:10 PM View: | Cempra, Inc. (MLNT) | 07-Mar-16 | Disposition (other) | 999,955 | -- | -- | (46%) 2.19M to 1.19M | |
| 06-Jan-16 5:07 PM View: | Cempra, Inc. (MLNT) | 04-Jan-16 | Option Exercise | 842 | -- | -- | < 1% 2.19M to 2.19M | |
| 06-Jan-16 5:07 PM View: | Cempra, Inc. (MLNT) | 04-Jan-16 | Market Option Sale (Planned) | 842 | $30.06 | $25,314.50 | (< 1%) 2.19M to 2.19M | 99% |
| 24-Jun-15 9:14 PM View: | Cempra, Inc. (MLNT) | 22-Jun-15 | Option Exercise | 50,000 | -- | -- | 2% 2.19M to 2.24M | |
| 24-Jun-15 9:14 PM View: | Cempra, Inc. (MLNT) | 22-Jun-15 | Market Option Sale (Planned) | 50,000 | $35.74 | $1,787,000.00 | (2%) 2.24M to 2.19M | 99% |
| 18-May-15 5:19 PM View: | Cempra, Inc. (MLNT) | 14-May-15 | Disposition (other) | 1,099,950 | -- | -- | (33%) 3.29M to 2.19M | |
| 30-Apr-15 4:26 PM View: | Esperion Therapeutics, Inc. (ESPR) | 28-Apr-15 | Disposition (other) | 199,991 | -- | -- | (11%) 1.84M to 1.64M | |
| 27-Apr-15 6:32 PM View: | Esperion Therapeutics, Inc. (ESPR) | 24-Apr-15 | Market Sale | 67,469 | $106.26 | $7,169,370.00 | (4%) 1.9M to 1.84M | 75% |
| 27-Apr-15 6:32 PM View: | Esperion Therapeutics, Inc. (ESPR) | 23-Apr-15 | Market Sale | 150,000 | $109.10 | $16,365,000.00 | (7%) 2.05M to 1.9M | 76% |
| 03-Apr-15 4:50 PM View: | Loxo Oncology, Inc. (LOXO) | 02-Apr-15 | Option Exercise | 4,005 | $6.40 | $25,628.80 | < 1% 3.51M to 3.52M | |
| 03-Apr-15 4:50 PM View: | Loxo Oncology, Inc. (LOXO) | 01-Apr-15 | Option Exercise | 39,212 | $6.46 | $253,249.00 | 1% 3.48M to 3.51M | |
| 06-Aug-14 4:12 PM View: | Loxo Oncology, Inc. (LOXO) | 06-Aug-14 | Conversion Duplicate | 2,850,710 | -- | -- | 1349% 211.36K to 3.06M | |
| 06-Aug-14 4:12 PM View: | Loxo Oncology, Inc. (LOXO) | 06-Aug-14 | Market Purchase Duplicate | 413,077 | $13.00 | $5,370,000.00 | 13% 3.06M to 3.48M | 1598% |
| 01-Jul-13 4:37 PM View: | Esperion Therapeutics, Inc. (ESPR) | 01-Jul-13 | Conversion Duplicate | 1,816,480 | -- | -- | 100% 0 to 1.82M | |
| 01-Jul-13 4:37 PM View: | Esperion Therapeutics, Inc. (ESPR) | 01-Jul-13 | Purchase Duplicate | 238,119 | $14.00 | $3,333,670.00 | 13% 1.82M to 2.05M | |
| 25-Jul-12 5:11 PM View: | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Conversion Duplicate | 2,019,710 | -- | -- | 100% 0 to 2.02M | |
| 25-Jul-12 5:11 PM View: | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Purchase Duplicate | 1,111,110 | $9.00 | $10,000,000.00 | 55% 2.02M to 3.13M | |
| 15-Feb-12 7:14 PM View: | Adma Biologics, Inc. (ADMA) | 13-Feb-12 | Grant | 2,516,860 | -- | -- | 100% 0 to 2.52M | |
| 09-Feb-12 12:34 PM View: | Cempra, Inc. (MLNT) | 07-Feb-12 | Purchase Duplicate | 1,213,660 | $6.00 | $7,281,980.00 | 58% 2.08M to 3.29M | |
| 10-Sep-04 3:56 PM View: | Vicuron Pharmaceuticals Inc (MICUD.PK) | 08-Sep-04 | Gift | 400 | -- | -- | (17%) 2.4K to 2.0K | |
| 10-Sep-04 3:56 PM View: | Vicuron Pharmaceuticals Inc (MICUD.PK) | 08-Sep-04 | Option Exercise | 400 | $4.72 | $1,888.00 | 20% 2.0K to 2.4K | |
| 17-Feb-04 10:00 PM View: | Vicuron Pharmaceuticals Inc (MICUD.PK) | 09-Sep-03 | Gift | 100 | -- | -- | (5%) 2.1K to 2.0K |